CONMED closed at $53.66 on Nov 4, up 13.61% — matching its 52-week closing high. Volume of 592.3K shares was 1.32× its 20-day average (above normal).
Split-adjusted performance: +20.6% over one month, +43.8% over six months, +19.6% over one year.
In the quarter ended Sep 30, 2026, revenue was $335.56M, down 0.7% from a year earlier, with a net margin of 5.9%.
Short interest was 1.9M shares at the Oct 15 settlement, down 2.2% from the prior report (6.4% of float, 4.7 days to cover).